UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pollution and respiratory disease: can diet or supplements help? A review

Respiratory research, 2018-05, Vol.19 (1), p.79-14, Article 79

2018

Volltextzugriff (PDF)

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms

British journal of cancer, 2013-05, Vol.108 (9), p.1838-1845

2013

Volltextzugriff (PDF)

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

Gut, 2012-01, Vol.61 (1), p.6-32

2012

Volltextzugriff (PDF)

Long‐term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel)

Alimentary pharmacology & therapeutics, 2011-07, Vol.34 (2), p.235-242

2011

Volltextzugriff (PDF)

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

British journal of cancer, 2010-03, Vol.102 (7), p.1106-1112

2010

Volltextzugriff (PDF)

Carcinoid tumour of the appendix

British journal of surgery, 2003-11, Vol.90 (11), p.1317-1322

2003

Volltextzugriff (PDF)

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

Annals of oncology, 2015-08, Vol.26 (8), p.1604-1620

2015

Volltextzugriff (PDF)

Expression of Somatostatin and Dopamine 2 Receptors in Neuroendocrine Tumours and the Potential Role for New Biotherapies

Neuroendocrinology, 2009-01, Vol.89 (3), p.308-314

2009

Volltextzugriff (PDF)

Long‐term results of patients with malignant carcinoid syndrome receiving octreotide LAR

Alimentary pharmacology & therapeutics, 2009-10, Vol.30 (7), p.733-740

2009

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Expression and Activation in Neuroendocrine Tumours

Journal of neuroendocrinology, 2006-05, Vol.18 (5), p.355-360

2006

Volltextzugriff (PDF)

A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer

European journal of cancer (1990), 2010-02, Vol.46 (3), p.526-533

2010

Volltextzugriff (PDF)

A review of thymic tumours

Lung cancer (Amsterdam, Netherlands), 2008-04, Vol.60 (1), p.4-13

2008

Volltextzugriff (PDF)

Surgical management and palliative treatment in bronchial neuroendocrine tumours: A clinical study of 45 patients

Lung cancer (Amsterdam, Netherlands), 2009-07, Vol.65 (1), p.68-73

2009

Volltextzugriff (PDF)

Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis

Endocrine-related cancer, 2009-09, Vol.16 (3), p.967-976

2009

Volltextzugriff (PDF)

Phase II Study of Anti–Gastrin-17 Antibodies, Raised to G17DT, in Advanced Pancreatic Cancer

Journal of clinical oncology, 2002-10, Vol.20 (20), p.4225-4231

2002

Volltextzugriff (PDF)

Sandostatin LAR (long‐acting octreotide acetate) for malignant carcinoid syndrome: a 3‐year experience

Alimentary pharmacology & therapeutics, 2003-02, Vol.17 (3), p.437-444

2003

Volltextzugriff (PDF)

Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours

Alimentary pharmacology & therapeutics, 2009-06, Vol.29 (11), p.1143-1154

2009

Volltextzugriff (PDF)

Carcinoid tumour

The Lancet (British edition), 1998-09, Vol.352 (9130), p.799-805

1998

Volltextzugriff (PDF)

α-Fetoprotein and human chorionic gonadotrophin-β as prognostic markers in neuroendocrine tumour patients

British journal of cancer, 2008-07, Vol.99 (1), p.72-77

2008

Volltextzugriff (PDF)

A comparison of CellCollector with CellSearch in patients with neuroendocrine tumours

Endocrine-related cancer, 2016-10, Vol.23 (10), p.L29-L32

2016

Volltextzugriff (PDF)

Comparison of the Utility of Cocaine- and Amphetamine-Regulated Transcript (CART), Chromogranin A, and Chromogranin B in Neuroendocrine Tumor Diagnosis and Assessment of Disease Progression

The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.1520-1528

2015

Volltextzugriff (PDF)

Obstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen's disease

European journal of gastroenterology & hepatology, 2005-11, Vol.17 (11), p.1229

2005

Volltextzugriff (PDF)

Anti-tuberculosis medication and the liver: dangers and recommendations in management

The European respiratory journal, 1995-08, Vol.8 (8), p.1384-1388

1995

Volltextzugriff (PDF)

CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines

Oncology reports, 2005-10, Vol.14 (4), p.1055

2005

Volltextzugriff (PDF)

Multimodality treatment for gastric carcinoid tumor with liver metastases

The American journal of gastroenterology, 1998-10, Vol.93 (10), p.1945-1948

1998

Volltextzugriff (PDF)

1 – 25 von 288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(269)
Mit Volltextzugriff
(239)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pollution and respiratory disease: can diet or supplements help? A review

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

Long‐term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel)

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

Carcinoid tumour of the appendix

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

Expression of Somatostatin and Dopamine 2 Receptors in Neuroendocrine Tumours and the Potential Role for New Biotherapies

Long‐term results of patients with malignant carcinoid syndrome receiving octreotide LAR

Epidermal Growth Factor Receptor Expression and Activation in Neuroendocrine Tumours

A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer

A review of thymic tumours

Surgical management and palliative treatment in bronchial neuroendocrine tumours: A clinical study of 45 patients

Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis

Phase II Study of Anti–Gastrin-17 Antibodies, Raised to G17DT, in Advanced Pancreatic Cancer

Sandostatin LAR (long‐acting octreotide acetate) for malignant carcinoid syndrome: a 3‐year experience

Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours

Carcinoid tumour

α-Fetoprotein and human chorionic gonadotrophin-β as prognostic markers in neuroendocrine tumour patients

A comparison of CellCollector with CellSearch in patients with neuroendocrine tumours

Comparison of the Utility of Cocaine- and Amphetamine-Regulated Transcript (CART), Chromogranin A, and Chromogranin B in Neuroendocrine Tumor Diagnosis and Assessment of Disease Progression

Obstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen's disease

Anti-tuberculosis medication and the liver: dangers and recommendations in management

CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines

Multimodality treatment for gastric carcinoid tumor with liver metastases

Suchergebnisse filtern